The global antibody drug conjugates market is anticipated to grow at a considerable CAGR during the forecast period. The antibody-drug conjugates are a significant group of highly potent bio-pharmaceutical drugs that are designed as a targeted treatment for the healing of cancer patients.
The increasing prevalence of cancer is pushing the demand for antibody drug conjugates market. For instance, in 2017, in the US, 1,701,315 new cases were reported of cancer, and 599,099 people died due to the same. Every 100,000 people, 438 new cancer cases were reported and 153 people died due to that. In 2020, it was estimated that 1,806,590 new cases of cancer were diagnosed in the US and there were 606,520 mortalities due to the disease.
To Request a Sample of our Report on Antibody Drug Conjugates Market: https://www.omrglobal.com/request-sample/antibody-drug-conjugates-market
Moreover, the availability of a large product pipeline and the increasing trend of cost-effective and quality cancer treatment are other factors that are driving the global antibody drug conjugates industry.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
Segment Covered-
· By Application
· By Technology
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
Competitive Landscape- AbbVie Inc., Astellas Pharma Inc., Bayer AG, Celldex Therapeutics, Inc., Creative Biolabs, Inc., ImmunoGen, Inc., Lonza Group, Pfizer Inc., Seattle Genetics, Inc.
Key Questions Addressed by the Report
· What is the market growth rate?
· Which segment and region dominate the market in the base year?
· Which segment and region will project the fastest growth in the market?
· How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
· Who is the leader in the market?
· How are players addressing challenges to sustain growth?
· Where is the investment opportunity?
(Get 15% Discount on Buying this Report)
A full Report of Antibody Drug Conjugates Market is Available at: https://www.omrglobal.com/industry-reports/antibody-drug-conjugates-market
Global Antibody Drug Conjugates Market Report Segment
By Application
· Blood Cancer
· Breast Cancer
· Ovarian Cancer
· Lung Cancer
· Others
By Technology
· Cleavable Linker
· Non-cleavable Linker
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
